第 1 到 68 筆結果,共 68 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2024 | miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44 | SHANG-GIN WU ; Chang, Tzu-Hua; Tsai, Meng-Feng; Liu, Yi-Nan; YEN-LIN HUANG ; Hsu, Chia-Lang; Jheng, Han-Nian; JIN-YUAN SHIH | Molecular therapy. Nucleic acids | |||
2 | 2024 | CD44s and CD44v8-10 isoforms confer acquired resistance to osimertinib by activating the ErbB3/STAT3 signaling pathway | Liu, Yi-Nan; Tsai, Meng-Feng; SHANG-GIN WU ; Chang, Tzu-Hua; JIN-YUAN SHIH | Life sciences | |||
3 | 2024 | Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancer | YEN-TING LIN ; CHAO-CHI HO ; Hsu, Wei-Hsun; WEI-YU LIAO ; CHING-YAO YANG ; CHONG-JEN YU ; TZU-HSIU TSAI ; CHIH-HSIN YANG ; SHANG-GIN WU ; CHIA-LIN HSU ; Hsieh, Min-Shu; YEN-LIN HUANG ; Wu, Chia-Ling; JIN-YUAN SHIH | Cancer medicine | 0 | ||
4 | 2023 | LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis | Chen, Yi-Ling; Liu, Yi-Nan; YEN-TING LIN ; Tsai, Meng-Feng; SHANG-GIN WU ; Chang, Tzu-Hua; CHIA-LANG HSU ; HUEY-DONG WU ; JIN-YUAN SHIH | Journal of biomedical science | 2 | 0 | |
5 | 2023 | Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors | DE-RUI HUANG ; BIN-CHI LIAO ; Hsu, Wei-Hsun; CHING-YAO YANG ; YEN-TING LIN ; SHANG-GIN WU ; TZU-HSIU TSAI ; KUAN-YU CHEN ; CHAO-CHI HO ; WEI-YU LIAO ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHIH-HSIN YANG ; ANN-LII CHENG ; YING-CHUN SHEN | Oncology | |||
6 | 2023 | Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system | CHING-YAO YANG ; JIN-YUAN SHIH ; WEI-YU LIAO ; CHAO-CHI HO ; CHIA-LIN HSU ; TZU-HSIU TSAI ; SHANG-GIN WU ; YEN-TING LIN ; Hsu, Wei-Hsun; Jain, Suyog; Olsen, Steve; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG | European journal of cancer (Oxford, England : 1990) | 0 | 0 | |
7 | 2023 | MiR-503 pleiotropically regulates epithelial-mesenchymal transition and targets PTK7 to control lung cancer metastasis | TZU-HSIU TSAI ; Gow, Chien-Hung; Liu, Yi-Nan; Tsai, Meng-Feng; Chang, Tzu-Hua; SHANG-GIN WU ; MIN-SHU HSIEH ; KANG-YI SU ; JIN-YUAN SHIH | Cancer medicine | 0 | 0 | |
8 | 2023 | Different treatment efficacies and T790M acquisition of EGFR-TKIs on NSCLC patients with variable Del-19 subtypes of EGFR | SHANG-GIN WU ; Gow, Chien-Hung; Chen, Yi-Ling; Liu, Yi-Nan; Tsai, Meng-Feng; JIN-YUAN SHIH | International journal of cancer | 2 | 1 | |
9 | 2023 | Multidisciplinary management of patients with non-small cell lung cancer with leptomeningeal metastasis in the tyrosine kinase inhibitor era | KUAN-YU CHEN ; SHANG-GIN WU ; DAR-MING LAI ; LU-TING KUO ; ABEL PO-HAO HUANG | Journal of neurosurgery | 1 | 0 | |
10 | 2023 | Survival outcomes and prognostic factors of lung cancer patients with the MET exon 14 skipping mutation: A single-center real-world study | Gow, Chien-Hung; MIN-SHU HSIEH ; Chen, Yi-Lin; Liu, Yi-Nan; SHANG-GIN WU ; JIN-YUAN SHIH | Frontiers in oncology | 1 | 1 | |
11 | 2022 | Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutations | Wang, H-Y; SHANG-GIN WU ; YEN-TING LIN ; CHUNG-YU CHEN ; JIN-YUAN SHIH | ESMO open | 3 | 3 | |
12 | 2022 | Prognostic significance of dynamin-related protein 1 expression in advanced lung adenocarcinoma | YEN-LIN HUANG ; Chen, Yi-Jung; Juan, Yi-Hsiu; SHANG-GIN WU ; KUEI-PIN CHUNG | Pathology, research and practice | 0 | 0 | |
13 | 2022 | 肺癌用藥 你該知道的事 | 臺大癌醫中心分院肺癌多專科診療團隊; JIN-SHING CHEN ; 莊仁豪; BIN-CHI LIAO ; 劉彥廷; YEN-TING LIN; ZONG-HAN YAO ; SHANG-GIN WU ; SHU-WEN LIN ; 何暐; 柯欣妏 | ||||
14 | 2022 | Cone-Beam Computed Tomography-Derived Augmented Fluoroscopy Improves the Diagnostic Yield of Endobronchial Ultrasound-Guided Transbronchial Biopsy for Peripheral Pulmonary Lesions | CHING-KAI LIN ; Fan, Hung-Jen; ZONG-HAN YAO ; YEN-TING LIN ; Wen, Yueh-Feng; SHANG-GIN WU ; CHAO-CHI HO | Diagnostics (Basel, Switzerland) | 5 | 2 | |
15 | 2022 | Recurrence of pericardial effusion after different procedure modalities in patients with non-small-cell lung cancer | Chang L.-K.; YAO-WEN KUO ; SHANG-GIN WU ; KUEI-PIN CHUNG ; JIN-YUAN SHIH | ESMO Open | 2 | 0 | |
16 | 2022 | Clinical outcomes of Atezolizumab Therapy for Previously-Treated Advanced-Stage Non-Small Cell Lung Cancer: A Real-World Study in Taiwan | SHANG-GIN WU ; Chiang, Chi-Lu; Wang, Chin-Chou; Hung, Jen-Yu; Hsia, Te-Chun; Kuo, Chih-Hsi; JIN-YUAN SHIH | Journal of Cancer | 1 | 1 | |
17 | 2021 | Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan | SHANG-GIN WU ; WEI-YU LIAO ; KANG-YI SU ; SUNG-LIANG YU ; YEN-LIN HUANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; JIN-YUAN SHIH | JTO Clinical and Research Reports | 16 | 0 | |
18 | 2021 | Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1 | KUEI-PIN CHUNG ; YEN-LIN HUANG ; Chen, Yi-Jung; Juan, Yi-Hsiu; Hsu, Chia-Lang ; Nakahira, Kiichi; Huang, Yen-Tsung; MONG-WEI LIN ; SHANG-GIN WU ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; CHONG-JEN YU | Molecular Oncology | 10 | 8 | |
19 | 2020 | miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway | Liu, Yi-Nan; Tsai, Meng-Feng; SHANG-GIN WU ; Chang, Tzu-Hua; TZU-HSIU TSAI ; Gow, Chien-Hung; Wang, Hsin-Yi; JIN-YUAN SHIH | Molecular therapy. Nucleic acids | 28 | 26 | |
20 | 2020 | MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process | Wang, Hsin-Yi; Liu, Yi-Nan; SHANG-GIN WU ; HSU, CHIA-LANG ; Chang, Tzu-Hua; Tsai, Meng-Feng; YEN-TING LIN ; JIN-YUAN SHIH | Cancer biomarkers : section A of Disease markers | 25 | 20 | |
21 | 2020 | Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer | YEN-TING LIN ; TZU-HSIU TSAI ; SHANG-GIN WU ; Liu Y.-N.; CHONG-JEN YU ; JIN-YUAN SHIH | Lung Cancer | 17 | 17 | |
22 | 2020 | An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan | SHANG-GIN WU ; Chiang, Chi-Lu; Liu, Chien-Ying; Wang, Chin-Chou; Su, Po-Lan; Hsia, Te-Chun; JIN-YUAN SHIH ; Chang, Gee-Chen | Frontiers in Oncology | 23 | 23 | |
23 | 2020 | The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation | SHANG-GIN WU ; CHONG-JEN YU ; CHIH-HSIN YANG ; JIN-YUAN SHIH | Therapeutic Advances in Medical Oncology | 16 | 15 | |
24 | 2019 | MicroRNA in lung cancer metastasis | SHANG-GIN WU ; Chang T.-H.; Liu Y.-N.; JIN-YUAN SHIH | Cancers | 53 | 47 | |
25 | 2019 | Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer | Liu Y.-N.; Tsai M.-F.; SHANG-GIN WU ; Chang T.-H.; TZU-HSIU TSAI ; Gow C.-H.; YIH-LEONG CHANG ; JIN-YUAN SHIH | International Journal of Cancer | 34 | 34 | |
26 | 2019 | High throughput sequencing of T-cell receptor repertoire using dry blood spots | SHANG-GIN WU ; Pan W.; Liu H.; Byrne-Steele M.L.; Brown B.; Depinet M.; Hou X.; Han J.; Li S. | Journal of Translational Medicine | 11 | 10 | |
27 | 2019 | IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer | SHANG-GIN WU ; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; CHIA-LANG HSU ; YIH-LEONG CHANG ; CHONG-JEN YU ; JIN-YUAN SHIH | Cancers | 15 | 12 | |
28 | 2018 | Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer | SHANG-GIN WU ; JIN-YUAN SHIH | Molecular Cancer | 474 | 422 | |
29 | 2018 | Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion | SHANG-GIN WU ; Liu Y.-N.; CHONG-JEN YU ; CHIH-HSIN YANG ; JIN-YUAN SHIH | Genes Chromosomes and Cancer | 11 | 10 | |
30 | 2017 | Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors | SHANG-GIN WU ; YIH-LEONG CHANG ; CHONG-JEN YU ; PAN-CHYR YANG ; JIN-YUAN SHIH | ERJ open research | 34 | 0 | |
31 | 2017 | A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population | Gow C.-H.; MIN-SHU HSIEH ; SHANG-GIN WU ; JIN-YUAN SHIH | Lung Cancer | 47 | 38 | |
32 | 2017 | Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C | Chang, Tzu-Hua; Tsai M.-F.; Gow, Chien-Hung; SHANG-GIN WU ; Liu, Yi-Nan; YIH-LEONG CHANG ; SUNG-LIANG YU ; HSING-CHEN TSAI ; Lin, Shih-Wen; Chen, Yen-Wei; Kuo, Po-Yen; PAN-CHYR YANG ; JIN-YUAN SHIH | Cancer letters | 48 | 47 | |
33 | 2017 | Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non–Small-cell Lung Cancer | YEN-TING LIN ; Liu Y.-N.; SHANG-GIN WU ; CHIH-HSIN YANG ; JIN-YUAN SHIH | Clinical Lung Cancer | 33 | 26 | |
34 | 2016 | The role of PIK3CA mutations among lung adenocarcinoma patients with primary and acquired resistance to EGFR tyrosine kinase inhibition | SHANG-GIN WU ; YIH-LEONG CHANG ; CHONG-JEN YU ; PAN-CHYR YANG ; JIN-YUAN SHIH | Scientific Reports | 35 | 28 | |
35 | 2016 | Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma | SHANG-GIN WU ; Liu Y.-N.; CHONG-JEN YU ; PAN-CHYR YANG ; JIN-YUAN SHIH | JAMA Oncology | 20 | 16 | |
36 | 2016 | The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients | SHANG-GIN WU ; Liu Y.-N.; Tsai M.-F.; YIH-LEONG CHANG ; CHONG-JEN YU ; PAN-CHYR YANG ; CHIH-HSIN YANG ; Wen Y.-F.; JIN-YUAN SHIH | Oncotarget | 207 | 191 | |
37 | 2016 | Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations | YEN-FU CHEN ; MIN-SHU HSIEH ; SHANG-GIN WU ; YIH-LEONG CHANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG ; JIN-YUAN SHIH | Journal of Thoracic Oncology | 63 | 51 | |
38 | 2015 | Treatment outcome of patients with isoniazid mono-resistant tuberculosis | JUNG-YIEN CHIEN ; Chen Y.-T.; SHANG-GIN WU ; Lee J.-J.; JANN-YUAN WANG ; CHONG-JEN YU | Clinical Microbiology and Infection | 46 | 38 | |
39 | 2015 | EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway | Tsai M.-F.; Chang T.-H.; SHANG-GIN WU ; Yang H.-Y.; Hsu Y.-C.; PAN-CHYR YANG ; JIN-YUAN SHIH | Scientific Reports | 48 | 43 | |
40 | 2015 | Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion | TZU-HSIU TSAI ; SHANG-GIN WU ; MIN-SHU HSIEH ; CHONG-JEN YU ; CHIH-HSIN YANG ; JIN-YUAN SHIH | Lung Cancer | 42 | 38 | |
41 | 2015 | IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer | Liu Y.-N.; Chang T.-H.; Tsai M.-F.; SHANG-GIN WU ; TZU-HSIU TSAI ; Chen H.-Y.; SUNG-LIANG YU ; CHIH-HSIN YANG ; JIN-YUAN SHIH | Oncotarget | 58 | 56 | |
42 | 2014 | Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer | YEN-TING LIN ; YU-FEN WANG ; CHIH-HSIN YANG ; CHONG-JEN YU ; SHANG-GIN WU ; JIN-YUAN SHIH ; PAN-CHYR YANG | Journal of Thoracic Oncology | 50 | 38 | |
43 | 2014 | Multidriver mutation analysis in pulmonary mucinous adenocarcinoma in Taiwan: Identification of a rare CD74-NRG1 translocation case | Gow C.-H.; SHANG-GIN WU ; YIH-LEONG CHANG ; JIN-YUAN SHIH | Medical Oncology | 24 | 21 | |
44 | 2014 | Brain Metastasis of Patients with Lung Adenocarcinoma: Epidermal Growth Factor Receptor Mutations and Response to Whole-Brain Radiation Therapy | SHANG-GIN WU ; JIN-YUAN SHIH | Brain Metastases from Primary Tumors: Epidemiology, Biology, and Therapy | 0 | 0 | |
45 | 2014 | Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations | YEN-FU CHEN ; MIN-SHU HSIEH ; SHANG-GIN WU ; YIH-LEONG CHANG ; JIN-YUAN SHIH ; Liu Y.-N.; Tsai M.-F.; TZU-HSIU TSAI ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG | Journal of Thoracic Oncology | 69 | 64 | |
46 | 2013 | Survival of lung adenocarcinoma patients with malignant pleural effusion | SHANG-GIN WU ; CHONG-JEN YU ; Tsai M.-F.; WEI-YU LIAO ; CHIH-HSIN YANG ; I-SHIOW JAN ; PAN-CHYR YANG ; JIN-YUAN SHIH | European Respiratory Journal | 87 | 77 | |
47 | 2013 | Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas | Wu P.-F.; Huang W.-C.; CHIH-HSIN YANG ; YEN-SHEN LU ; JIN-YUAN SHIH ; SHANG-GIN WU ; CHING-HUNG LIN ; ANN-LII CHENG | Journal of Neuro-Oncology | 8 | 5 | |
48 | 2013 | Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis | SHANG-GIN WU ; Hu F.-C.; YIH-LEONG CHANG ; Lee Y.-C.; CHONG-JEN YU ; YEUN-CHUNG CHANG ; Wu J.-Y.; JIN-YUAN SHIH ; PAN-CHYR YANG | European Respiratory Journal | 35 | 36 | |
49 | 2012 | Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma | TZU-HSIU TSAI ; SHANG-GIN WU ; YIH-LEONG CHANG ; CHEN-TU WU ; Tsai M.-F.; Wei P.-F.; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG ; JIN-YUAN SHIH | Journal of Thoracic Oncology | 22 | 26 | |
50 | 2012 | Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR | KUEI-PIN CHUNG ; SHANG-GIN WU ; Wu J.-Y.; CHIH-HSIN YANG ; CHONG-JEN YU ; Wei P.-F.; JIN-YUAN SHIH ; PAN-CHYR YANG | Clinical Cancer Research | 60 | 55 | |
51 | 2012 | EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR | SHANG-GIN WU ; YAO-WEN KUO ; YIH-LEONG CHANG ; JIN-YUAN SHIH ; Chen Y.-H.; Tsai M.-F.; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG | Journal of Thoracic Oncology | 90 | 72 | |
52 | 2012 | Brain metastasis in NSCLC patients: Mechanism, diagnosis and treatment | SHANG-GIN WU ; JIN-YUAN SHIH | International Journal of Cancer Research and Prevention | 0 | ||
53 | 2012 | RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer | TZU-HSIU TSAI ; KANG-YI SU ; SHANG-GIN WU ; YIH-LEONG CHANG ; Luo S.-C.; Jane I.-S.; CHONG-JEN YU ; Yue S.-L.; JIN-YUAN SHIH ; PAN-CHYR YANG | European Respiratory Journal | 42 | 37 | |
54 | 2011 | Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction | SHANG-GIN WU ; YIH-LEONG CHANG ; JOU-WEI LIN ; CHEN-TU WU ; Chen, Hsuan-Yu; Tsai, Meng-Feng; Lee, Yung-Chie; CHONG-JEN YU ; JIN-YUAN SHIH | PloS one | 49 | 43 | |
55 | 2011 | Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations | Wu J.-Y.; SHANG-GIN WU ; CHIH-HSIN YANG ; YIH-LEONG CHANG ; YEUN-CHUNG CHANG ; Hsu Y.-C.; JIN-YUAN SHIH ; PAN-CHYR YANG | Lung Cancer | 69 | 61 | |
56 | 2011 | Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations | SHANG-GIN WU ; CHIH-HSIN YANG ; CHONG-JEN YU ; JIH-HSIANG LEE ; Hsu Y.-C.; YIH-LEONG CHANG ; JIN-YUAN SHIH ; PAN-CHYR YANG | Lung Cancer | 41 | 35 | |
57 | 2011 | Pericardial pigtail knotting | SHANG-GIN WU ; JIN-YUAN SHIH | European Journal of Cardio-thoracic Surgery | 3 | 3 | |
58 | 2011 | Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor | Chang T.-H.; Tsai M.-F.; KANG-YI SU ; SHANG-GIN WU ; Huang C.-P.; SUNG-LIANG YU ; Yu Y.-L.; Lan C.-C.; CHIH-HSIN YANG ; Lin S.-B.; Wu C.-P.; JIN-YUAN SHIH ; PAN-CHYR YANG | American Journal of Respiratory and Critical Care Medicine | 145 | 140 | |
59 | 2011 | Acute cytomegalovirus pneumonitis in patient with lymphomatoid granulomatosis | SHANG-GIN WU ; TZU-HSIU TSAI ; SHANG-JU WU | Emerging Infectious Diseases | 3 | 2 | |
60 | 2010 | Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation | YAO-WEN KUO ; SHANG-GIN WU ; CHAO-CHI HO ; JIN-YUAN SHIH | Journal of Thoracic Oncology | 73 | 67 | |
61 | 2010 | Disseminated Cryptococcus neoformans var. grubii infections in intensive care units | Chuang Y.-M.; SHIH-CHI KU ; SHWU-JEN LIAW ; SHANG-GIN WU ; Ho Y.C.; CHONG-JEN YU ; PO-REN HSUEH | Epidemiology and Infection | 7 | 6 | |
62 | 2009 | Successful weaning after plasma exchange for polyneuropathy related to POEMS syndrome | SHANG-GIN WU ; PING-HUNG KUO ; PAN-CHYR YANG | Journal of Clinical Apheresis | 1 | 1 | |
63 | 2009 | Critical illness polyneuromyopathy in a patient with disseminated cryptococcal infection | Wu J.-Y.; SHANG-GIN WU ; HSIN-YUN SUN ; PING-HUNG KUO ; PAN-CHYR YANG | Journal of Hospital Medicine | 1 | 0 | |
64 | 2008 | Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern | SHANG-GIN WU ; YIH-LEONG CHANG ; Hsu Y.-C.; Wu J.-Y.; CHIH-HSIN YANG ; CHONG-JEN YU ; Tsai M.-F.; JIN-YUAN SHIH ; PAN-CHYR YANG | Oncologist | 73 | 67 | |
65 | 2008 | Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma | SHANG-GIN WU ; Gow C.-H.; CHONG-JEN YU ; YIH-LEONG CHANG ; CHIH-HSIN YANG ; Hsu Y.-C.; JIN-YUAN SHIH ; Lee Y.-C.; PAN-CHYR YANG | European Respiratory Journal | 109 | 95 | |
66 | 2008 | Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response | Wu J.-Y.; SHANG-GIN WU ; CHIH-HSIN YANG ; Gow C.-H.; YIH-LEONG CHANG ; CHONG-JEN YU ; Shin J.-Y.; PAN-CHYR YANG | Clinical Cancer Research | 278 | 250 | |
67 | 2008 | First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer | Wu J.-Y.; CHONG-JEN YU ; CHIH-HSIN YANG ; SHANG-GIN WU ; Chiu Y.-H.; Gow C.-H.; YEUN-CHUNG CHANG ; Hsu Y.-C.; Wei P.-F.; JIN-YUAN SHIH ; PAN-CHYR YANG | American Journal of Respiratory and Critical Care Medicine | 69 | 62 | |
68 | 2008 | Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation | SHANG-GIN WU ; JIN-YUAN SHIH ; CHONG-JEN YU ; PAN-CHYR YANG | Journal of Thoracic Oncology | 11 | 9 |